Exosomal miR-27a-5p Helps Differentiate Parathyroid Carcinoma From Adenoma and Inhibits Apoptosis in Parathyroid Carcinoma Cells
A blood-based test using exosomal particles shows promise in distinguishing dangerous parathyroid cancer from benign tumors.
Serum exosomal miR-27a-5p demonstrated significant differential expression and diagnostic utility in distinguishing parathyroid carcinoma from adenoma (n=29 vs 36 cases), with a dual role in suppressing tumor apoptosis through PIK3CA. This represents a promising noninvasive liquid biopsy approach for a diagnostically challenging rare endocrine tumor.
What the study was
- Study design
- Diagnostic accuracy study + in vitro mechanistic
- Population
- Parathyroid carcinoma (n=29) and adenoma (n=36) patients; serum exosome profiling
- Sample size
- 65
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- International Journal of Endocrinology
Why it surfaced
Noninvasive liquid biopsy approach for rare diagnostically challenging endocrine cancer; mechanistic target (PIK3CA) identified; small n limits confidence.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.